Review Article
    Pharmacognosy Reviews
    Vol. 16
    Issue 31
    2022
    pp. 34-39
    Open Access

    Reactualiting Phanera semibifida (Roxb.) Benth. from Sumatra, Indonesia as an Anticancer Agent and Phylogenetic Position

    Fitmawati F1,Erwina Juliantari2,Rodesia Mustika Roza1,Titrawani t1,Vanda Julita Yahya1
    1Department of Biology, Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Riau, INDONESIA.
    2Plant Biology Graduate Program, Department of Biology, Faculty of Mathematic and Natural, IPB University, Bogor, West Java, INDONESIA.
    Correspondence:

    *Fitmawati F

    Department of Biology Faculty of Mathematics and Natural Sciences, Universitas Riau, Pekanbaru, Riau, INDONESIA.

    fitmawati2008@yahoo.com

    Copyright:

    2022 Author(s)

    Check for updates
    Published:28/01/2022
    Received: 26/11/2021
    Accepted: 20/01/2022

    Abstract

    The increasing prevalence of cancer worldwide demands the intensification of efforts to develop natural solutions for its treatment. Herbal plants have provided a strong evident base in treating of this disease in many indigenous tribes in the world. Phanera semibifida has been widely used as a viable anti-degenerative drug for cancer treatment. This study reviews selected plant species with taxonomy status, phylogeny position, phytochemistry and pharmacology study based on a author’s research and literature review conducted through relevant keyword searches in databases, Web of Science, Scopus, PubMed, and Google Scholar. Detailed analysis of research studies proves that P. semibfida can be used as an anticancer agent with strong basic evidence based on indigenous knowledge from traditional communities.

    Share on Mobile

    Scan to access on mobile

    Keywords

    Anticancer
    Leguminosae
    Phanera semibifida
    Pharmacology
    Sumatra
    No content available

    Related Articles